Mental and physical well-being of childhood, adolescent and young adult cancer survivors Mental and Behavioural Disorders
Conditions
Interventions
This is a multi-center mixed-method randomized controlled trial with a two-armed parallel design using individual randomization in which participants are allocated to a wilderness program or a holiday
2) A three-month in-between period where participants are contacted once every month online to coach them to engage in their outdoor activities
3) A four-day interventio
Sponsors
Mid Sweden University
Eligibility
Sex/Gender
All
Age
16 Years to 39 Years
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 15/04/2024: 1. Adolescents and young adults (AYA) aged 16-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood 2. To be able to walk 2 km a day (walking aids or assistance from another person is permitted) 3. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs. 4. Prior experience with outdoor activities is not required for participation Previous inclusion criteria: 1. Adolescents and young adults (AYA) aged 16-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood 2. To be able to walk 2 km without pausing (walking aids or assistance from another person is permitted) 3. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs. 4. Prior experience with outdoor activities is not required for participation
Exclusion criteria
Exclusion criteria: 1. Active cancer treatment for which participation in the study can involve unwanted risks as evaluated by the treating physician/oncologist 2. A medical condition that prevents safe travel to, or participation in the program 3. Not willing to be randomly assigned 4. Previous participation in the WAYA 1 study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 15/04/2024: 1. Psychological well-being measured using the Psychological Well-being Scale (PWS) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention 2. Nature connectedness measured using the Nature Relatedness Scale (NRS) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention. Previous primary outcome measures: 1. Psychological well-being measured using the Psychological Well-being Scale (PWS) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention 2. Quality of life of childhood and adolescent and young adult (AYA) cancer survivors measured using the Minneapolis Manchester Quality of Life instrument (MMQL) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention 3. Nature connectedness measured using the Nature Relatedness Scale (NRS) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 15/04/2024: 1. Quality of life of childhood and adolescent and young adult (AYA) cancer survivors measured using the Minneapolis Manchester Quality of Life instrument (MMQL) at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention And copy this under the section as secondary outcome measure. 2. Changes in physical activity measured using an ActiGraph at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention 3. Changes in estimated maximal oxygen consumption (VO2max; ml/kg/min) measured using the Ekblom Bak cycle ergometer test at baseline and at 3 months after the first intervention 4. Blood Pressure and Heart Rate (BP/HR) measured using an electronic monitor in a seated position after a 5-min rest at baseline and at 3 months after the first intervention. 5. Body mass index (BMI) (kg/m2) will be calculated from body mass measured non-fasted and in light clothing to the nearest 0.1 kg using a digital scale and height measured to the nearest 1 mm using a stadiometer at baseline and at 3 months after the first intervention. 6. Occurrence of (serious) adverse effects during both programs measured using the number, seriousness, intensity, and types of adverse effects that are evaluated to be certain, probable/likely, or possibly related to the study programs in study records after the first 8-day intervention, at 1, 2 and 3 months and 1 year after the first intervention. Previous secondary outcome measures: 1. Changes in physical activity measured using an ActiGraph at baseline, directly after the first 8-day intervention, at 3 months and 1 year after the first intervention 2. Changes in estimated maximal oxygen consumption (VO2max; ml/kg/min) measured using the Ekblom Bak cycle ergometer test at baseline and at 3 months after the first intervention 3. Blood Pressure and Heart Rate (BP/HR) measured using an electronic monitor | — |
Countries
Norway, Sweden
Contacts
Public ContactMats Jong
Outcome results
None listed